Evidence map›Paper›PMID 24045890›Full record

ReviewVeterinary pathology2014

MicroRNAs: history, biogenesis, and their evolving role in animal development and disease.

M Bhaskaran, M Mohan

Abstract readHistorical ArticleReview
In one paragraph

Review in Veterinary pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 334 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
334citing papers in PubMed, 4 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

334 citing papers in PubMed, 4 syntheses or guidelines pooled it, 603 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. miR‑205: A dual regulator of angiogenesis in health and disease (Review).International journal of molecular medicine · 2026
    Review
  18. Article
  19. Review
  20. Article

274 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

M BhaskaranInfectious Disease Aerobiology, Division of Microbiology, Tulane National Primate Research Center, Covington, LA, USA mbhaska@tulane.edu.
M MohanDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, USA.
Tulane University · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
ZCM:A NOVEL BROAD-SPECTRUM MICROBICIDE FOR SEXUALLY TRANSMITTED INFECTIONSP51RR000164 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI VEAZEY, RONALD S. · 1985 to 2011
$100.1M
Research Training in Experimental Medicine and PathologyT32OD011124 · OD · TULANE UNIVERSITY OF LOUISIANA · PI BLAIR, ROBERT, RAPPAPORT, JAY · 2012 to 2019
$2.7M
Research Training in Experimental Medicine and PathologyT32RR021309 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI LACKNER, ANDREW A · 2005 to 2011
$2.3M
Molecular Pathology of HIV/SIV EnteropathyR01DK083929 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI MOHAN, MAHESH · 2010 to 2014
$1.7M
NCRR NIH HHS P51 RR000164NCRR NIH HHS RR00164NCRR NIH HHS T32 RR021309NIDDK NIH HHS R01 DK083929NIDDK NIH HHS R01DK083929NIH HHS OD011104NIH HHS P51 OD011104NIH HHS T32 OD011124NIH HHS T32-OD011124
6 · The paper itself

Abstract

The discovery of microRNAs (miRNAs) in 1993 followed by developments and discoveries in small RNA biology have redefined the biological landscape by significantly altering the longstanding dogmas that defined gene regulation. These small RNAs play a significant role in modulation of an array of physiological and pathological processes ranging from embryonic development to neoplastic progression. Unique miRNA signatures of various inherited, metabolic, infectious, and neoplastic diseases have added a new dimension to the studies that look at their pathogenesis and highlight their potential to be reliable biomarkers. Also, altering miRNA functionality and the development of novel in vivo delivery systems to achieve targeted modulation of specific miRNA function are being actively pursued as novel approaches for therapeutic intervention in many diseases. Here we review the current body of knowledge on the role of miRNAs in development and disease and discuss future implications.

Indexed as

Models, BiologicalAnimal DiseasesAnimalsBiomarkersGrowth and DevelopmentHistory, 20th CenturyHistory, 21st CenturyMicroRNAsBiomarkersMicroRNAsanimal microRNAapoptomiRbiomarkerscirculating miRNAmiRoncomiR

Identifiers

PMID24045890
PMCPMC4013251
OpenAlexW2103328194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.